Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELBASVIR\GRAZOPREVIR for Acute hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ELBASVIR\GRAZOPREVIR was used for Acute hepatitis c.

Most Reported Side Effects for ELBASVIR\GRAZOPREVIR

Side Effect Reports % Deaths Hosp.
Fatigue 912 21.7% 3 36
Headache 704 16.8% 1 27
Nausea 447 10.6% 1 32
Drug dose omission 254 6.1% 0 33
Diarrhoea 253 6.0% 3 17
Insomnia 195 4.6% 2 7
Hepatitis c 175 4.2% 1 4
Vomiting 145 3.5% 4 38
Adverse event 134 3.2% 6 50
Dizziness 119 2.8% 0 9
Decreased appetite 112 2.7% 2 21
Treatment failure 98 2.3% 0 2
Constipation 91 2.2% 1 5
No adverse event 90 2.1% 1 1
Pruritus 90 2.1% 0 1

Other Indications for ELBASVIR\GRAZOPREVIR

Hepatitis c (2,119) Chronic hepatitis c (736) Product used for unknown indication (40) Hepatitis (23) Hepatitis c virus test positive (23) Hepatic cirrhosis (20) Hepatitis viral (20) Essential hypertension (15) Chronic hepatitis (14) Hepatitis b (14)

Other Drugs Used for Acute hepatitis c

LEDIPASVIR\SOFOSBUVIR (38) SOFOSBUVIR\VELPATASVIR (29) RIBAVIRIN (26) SOFOSBUVIR (19) PEGINTERFERON ALFA-2A (17) GLECAPREVIR\PIBRENTASVIR (12) DACLATASVIR (10) PEGINTERFERON ALFA-2B (8) ETANERCEPT (6)

Related Pages

ELBASVIR\GRAZOPREVIR Full Profile All Acute hepatitis c Drugs ELBASVIR\GRAZOPREVIR Demographics ELBASVIR\GRAZOPREVIR Timeline